TK1 and hepatocellular carcinoma: Previous results showed that the levels of serum TK1 (thymidine kinase 1) in the primary hepatic carcinoma group were significantly higher than those in the control group and the benign group (P ≤ 0.05) (Shen-Jie & Li, 2018; Zhang, Lin & Li, 2015).